REPORT ID 395

Global Indoleamine 2,3 Dioxygenase 1 Market Research Report 2017

Publish Date
01-Dec-17
Pages
115
Format
Electronic (PDF)

In this report, the global Indoleamine 2,3 Dioxygenase 1 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Indoleamine 2,3 Dioxygenase 1 in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Indoleamine 2,3 Dioxygenase 1 market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    BirchBioMed Inc
    Bristol-Myers Squibb Company
    Ensemble Therapeutics Corp
    F. Hoffmann-La Roche Ltd
    Genentech Inc
    Globavir Biosciences Inc
    Incyte Corp
    IO Biotech ApS
    Kyowa Hakko Kirin
    Netherlands Translational Research Center BV
    NewLink Genetics Corp
    Pfizer Inc
    Redx Pharma Plc
    Regen BioPharma Inc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    BMS-986205
    Dcellvax
    Epacadostat
    F-001287
    Galanal
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Aolpecia
    Cervical Cancer
    Gastric Cancer
    Glioma
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Indoleamine 2,3 Dioxygenase 1 Market Research Report 2017
1 Indoleamine 2,3 Dioxygenase 1 Market Overview
    1.1 Product Overview and Scope of Indoleamine 2,3 Dioxygenase 1
    1.2 Indoleamine 2,3 Dioxygenase 1 Segment by Type (Product Category)
        1.2.1 Global Indoleamine 2,3 Dioxygenase 1 Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Indoleamine 2,3 Dioxygenase 1 Production Market Share by Type (Product Category) in 2016
        1.2.3 BMS-986205
        1.2.4 Dcellvax
        1.2.5 Epacadostat
        1.2.6 F-001287
        1.2.7 Galanal
        1.2.8 Others
    1.3 Global Indoleamine 2,3 Dioxygenase 1 Segment by Application
        1.3.1 Indoleamine 2,3 Dioxygenase 1 Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Aolpecia
        1.3.3 Cervical Cancer
        1.3.4 Gastric Cancer
        1.3.5 Glioma
        1.3.6 Others
    1.4 Global Indoleamine 2,3 Dioxygenase 1 Market by Region (2012-2022)
        1.4.1 Global Indoleamine 2,3 Dioxygenase 1 Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Indoleamine 2,3 Dioxygenase 1 (2012-2022)
        1.5.1 Global Indoleamine 2,3 Dioxygenase 1 Revenue Status and Outlook (2012-2022)
        1.5.2 Global Indoleamine 2,3 Dioxygenase 1 Capacity, Production Status and Outlook (2012-2022)

2 Global Indoleamine 2,3 Dioxygenase 1 Market Competition by Manufacturers
    2.1 Global Indoleamine 2,3 Dioxygenase 1 Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Indoleamine 2,3 Dioxygenase 1 Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Indoleamine 2,3 Dioxygenase 1 Production and Share by Manufacturers (2012-2017)
    2.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Indoleamine 2,3 Dioxygenase 1 Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Indoleamine 2,3 Dioxygenase 1 Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Indoleamine 2,3 Dioxygenase 1 Market Competitive Situation and Trends
        2.5.1 Indoleamine 2,3 Dioxygenase 1 Market Concentration Rate
        2.5.2 Indoleamine 2,3 Dioxygenase 1 Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Indoleamine 2,3 Dioxygenase 1 Capacity and Market Share by Region (2012-2017)
    3.2 Global Indoleamine 2,3 Dioxygenase 1 Production and Market Share by Region (2012-2017)
    3.3 Global Indoleamine 2,3 Dioxygenase 1 Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Indoleamine 2,3 Dioxygenase 1 Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Indoleamine 2,3 Dioxygenase 1 Consumption by Region (2012-2017)
    4.2 North America Indoleamine 2,3 Dioxygenase 1 Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Indoleamine 2,3 Dioxygenase 1 Production, Consumption, Export, Import (2012-2017)
    4.4 China Indoleamine 2,3 Dioxygenase 1 Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Indoleamine 2,3 Dioxygenase 1 Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Production, Consumption, Export, Import (2012-2017)
    4.7 India Indoleamine 2,3 Dioxygenase 1 Production, Consumption, Export, Import (2012-2017)

5 Global Indoleamine 2,3 Dioxygenase 1 Production, Revenue (Value), Price Trend by Type
    5.1 Global Indoleamine 2,3 Dioxygenase 1 Production and Market Share by Type (2012-2017)
    5.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue and Market Share by Type (2012-2017)
    5.3 Global Indoleamine 2,3 Dioxygenase 1 Price by Type (2012-2017)
    5.4 Global Indoleamine 2,3 Dioxygenase 1 Production Growth by Type (2012-2017)

6 Global Indoleamine 2,3 Dioxygenase 1 Market Analysis by Application
    6.1 Global Indoleamine 2,3 Dioxygenase 1 Consumption and Market Share by Application (2012-2017)
    6.2 Global Indoleamine 2,3 Dioxygenase 1 Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Indoleamine 2,3 Dioxygenase 1 Manufacturers Profiles/Analysis
    7.1 BirchBioMed Inc
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Bristol-Myers Squibb Company
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Ensemble Therapeutics Corp
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 F. Hoffmann-La Roche Ltd
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Genentech Inc
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Globavir Biosciences Inc
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Incyte Corp
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 IO Biotech ApS
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Kyowa Hakko Kirin
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Netherlands Translational Research Center BV
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Indoleamine 2,3 Dioxygenase 1 Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 NewLink Genetics Corp
    7.12 Pfizer Inc
    7.13 Redx Pharma Plc
    7.14 Regen BioPharma Inc

8 Indoleamine 2,3 Dioxygenase 1 Manufacturing Cost Analysis
    8.1 Indoleamine 2,3 Dioxygenase 1 Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Indoleamine 2,3 Dioxygenase 1

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Indoleamine 2,3 Dioxygenase 1 Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Indoleamine 2,3 Dioxygenase 1 Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Indoleamine 2,3 Dioxygenase 1 Market Forecast (2017-2022)
    12.1 Global Indoleamine 2,3 Dioxygenase 1 Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Indoleamine 2,3 Dioxygenase 1 Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Indoleamine 2,3 Dioxygenase 1 Price and Trend Forecast (2017-2022)
    12.2 Global Indoleamine 2,3 Dioxygenase 1 Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Indoleamine 2,3 Dioxygenase 1 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Indoleamine 2,3 Dioxygenase 1 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Indoleamine 2,3 Dioxygenase 1 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Indoleamine 2,3 Dioxygenase 1 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Indoleamine 2,3 Dioxygenase 1 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Indoleamine 2,3 Dioxygenase 1 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Indoleamine 2,3 Dioxygenase 1 Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Indoleamine 2,3 Dioxygenase 1 Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer